Veradigm Price to Sales Ratio 2010-2022 | MDRX
Veradigm P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2025-05-23 | 4.45 | 0.94 | |
2022-12-31 | 17.64 | $4.75 | 3.71 |
2022-09-30 | 15.23 | $4.62 | 3.30 |
2022-06-30 | 14.83 | $4.54 | 3.27 |
2022-03-31 | 22.52 | $4.24 | 5.31 |
2021-12-31 | 18.45 | $4.11 | 4.49 |
2021-09-30 | 13.37 | $-0.55 | 0.00 |
2021-06-30 | 18.51 | $0.62 | 29.85 |
2021-03-31 | 15.02 | $1.92 | 7.83 |
2020-12-31 | 14.44 | $3.37 | 4.29 |
2020-09-30 | 8.14 | $8.76 | 0.93 |
2020-06-30 | 6.77 | $9.16 | 0.74 |
2020-03-31 | 7.04 | $9.56 | 0.74 |
2019-12-31 | 9.82 | $9.76 | 1.01 |
2019-09-30 | 10.98 | $9.64 | 1.14 |
2019-06-30 | 11.63 | $9.45 | 1.23 |
2019-03-31 | 9.54 | $9.24 | 1.03 |
2018-12-31 | 9.64 | $9.11 | 1.06 |
2018-09-30 | 14.25 | $8.50 | 1.68 |
2018-06-30 | 12.00 | $8.52 | 1.41 |
2018-03-31 | 12.35 | $8.40 | 1.47 |
2017-12-31 | 14.55 | $8.28 | 1.76 |
2017-09-30 | 14.23 | $8.53 | 1.67 |
2017-06-30 | 12.76 | $8.15 | 1.57 |
2017-03-31 | 12.68 | $7.87 | 1.61 |
2016-12-31 | 10.21 | $7.39 | 1.38 |
2016-09-30 | 13.17 | $7.86 | 1.68 |
2016-06-30 | 12.70 | $7.62 | 1.67 |
2016-03-31 | 13.21 | $7.49 | 1.76 |
2015-12-31 | 15.38 | $7.53 | 2.04 |
2015-09-30 | 12.40 | $7.56 | 1.64 |
2015-06-30 | 13.68 | $7.60 | 1.80 |
2015-03-31 | 11.96 | $7.62 | 1.57 |
2014-12-31 | 12.77 | $7.67 | 1.67 |
2014-09-30 | 13.42 | $7.75 | 1.73 |
2014-06-30 | 16.05 | $7.69 | 2.09 |
2014-03-31 | 18.03 | $7.68 | 2.35 |
2013-12-31 | 15.46 | $7.78 | 1.99 |
2013-09-30 | 14.87 | $7.76 | 1.92 |
2013-06-30 | 12.94 | $7.99 | 1.62 |
2013-03-31 | 13.59 | $8.05 | 1.69 |
2012-12-31 | 9.42 | $7.95 | 1.19 |
2012-09-30 | 12.42 | $8.02 | 1.55 |
2012-06-30 | 10.93 | $7.83 | 1.40 |
2012-03-31 | 16.60 | $7.67 | 2.16 |
2011-12-31 | 18.94 | $7.52 | 2.52 |
2011-09-30 | 18.02 | $7.18 | 2.51 |
2011-06-30 | 19.42 | $6.80 | 2.86 |
2011-03-31 | 20.99 | $6.23 | 3.37 |
2010-12-31 | 19.27 | $4.49 | 4.29 |
2010-09-30 | 18.47 | $4.04 | 4.58 |
2010-06-30 | 16.10 | $3.73 | 4.31 |
2010-05-31 | 18.81 | $2.45 | 7.66 |
2010-03-31 | 19.58 | $3.58 | 5.47 |
2010-02-28 | 17.89 | $3.46 | 5.18 |
2009-12-31 | 20.23 | $3.34 | 6.06 |
2009-11-30 | 19.20 | $3.34 | 5.75 |
2009-09-30 | 20.27 | $3.28 | 6.18 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.476B | $0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $37.908B | 52.36 |
Hims & Hers Health (HIMS) | United States | $12.273B | 127.51 |
Tempus AI (TEM) | United States | $10.774B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.555B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.224B | 66.00 |
Privia Health (PRVA) | United States | $2.787B | 190.50 |
Enovis (ENOV) | United States | $1.803B | 10.05 |
Clover Health Investments (CLOV) | United States | $1.623B | 0.00 |
Schrodinger (SDGR) | United States | $1.563B | 0.00 |
Phreesia (PHR) | United States | $1.431B | 0.00 |
Omnicell (OMCL) | United States | $1.322B | 23.33 |
Azenta (AZTA) | United States | $1.236B | 57.45 |
10x Genomics (TXG) | United States | $1.006B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
Butterfly Network (BFLY) | United States | $0.537B | 0.00 |
Talkspace (TALK) | United States | $0.472B | 141.00 |
Claritev (CTEV) | United States | $0.437B | 0.00 |
TruBridge (TBRG) | United States | $0.357B | 791.00 |
Standard BioTools (LAB) | United States | $0.350B | 0.00 |
Outset Medical (OM) | United States | $0.318B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.190B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.140B | 0.00 |
Pulmonx (LUNG) | United States | $0.125B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
CareCloud (CCLD) | United States | $0.084B | 3.21 |
111 (YI) | China | $0.069B | 0.00 |
HeartBeam (BEAT) | United States | $0.056B | 0.00 |
P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.015B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |